We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here at Zacks, we used to have a service called “Follow the Money.” Similar to Insider Trader and how it follows insider buying, FTM used to follow institutional investor announcements. In today’s day and age, X is a great tool for gaining info on where the “smart money” might be moving. One of my favorite things to do is follow the investments of members of Congress. Sometimes, you find some gems that you’ve never thought of.
Here, Tempus AI (TEM - Free Report) is a name that Nancy Pelosi recently announced a stake in. She bought 50 of the January 2026 $20 call options on January 14th. Since that addition, the stock has seen a sizeable increase in trading volume and has nearly doubled, up 93%. Even after that move, it’s still off its all-time high near $80. With a market cap of $9.7 billion, there is plenty of upside potential. The company is at the center of the fusion of AI and healthcare. They tout themselves as “accelerating precision medicine with AI-enabled solutions for personalized healthcare.”
Moving Averages: Bartosiak starts by examining the stock's moving averages, such as the 50-day and 200-day moving averages. He points out the significance of crossovers and divergences between these averages, which can indicate potential trend changes.
Support and Resistance Levels: Bartosiak identifies key support and resistance levels on the chart. These levels act as barriers that the stock price must breach or hold above, providing traders with critical decision points.
Chart Patterns: He discusses chart patterns like head and shoulders, cup and handle, or flags, and their relevance in predicting future price movements. These patterns can offer valuable insights into potential bullish or bearish trends.
Volume Analysis: He emphasizes the importance of volume analysis in confirming price trends. An increase in trading volume during a breakout or breakdown can validate the significance of a price move.
Dave Bartosiak's technical analysis approach adds depth to our understanding Tempus AI stock chart. By paying attention to moving averages, support and resistance levels, chart patterns, technical indicators, and volume, he equips investors with a comprehensive toolkit for making well-informed decisions in the stock market. Remember, while technical analysis is a valuable tool, it's important to consider other factors like fundamental analysis and market sentiment before making investment choices.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Tempus AI Mixes Healthcare with AI
Here at Zacks, we used to have a service called “Follow the Money.” Similar to Insider Trader and how it follows insider buying, FTM used to follow institutional investor announcements. In today’s day and age, X is a great tool for gaining info on where the “smart money” might be moving. One of my favorite things to do is follow the investments of members of Congress. Sometimes, you find some gems that you’ve never thought of.
Here, Tempus AI (TEM - Free Report) is a name that Nancy Pelosi recently announced a stake in. She bought 50 of the January 2026 $20 call options on January 14th. Since that addition, the stock has seen a sizeable increase in trading volume and has nearly doubled, up 93%. Even after that move, it’s still off its all-time high near $80. With a market cap of $9.7 billion, there is plenty of upside potential. The company is at the center of the fusion of AI and healthcare. They tout themselves as “accelerating precision medicine with AI-enabled solutions for personalized healthcare.”
Moving Averages: Bartosiak starts by examining the stock's moving averages, such as the 50-day and 200-day moving averages. He points out the significance of crossovers and divergences between these averages, which can indicate potential trend changes.
Support and Resistance Levels: Bartosiak identifies key support and resistance levels on the chart. These levels act as barriers that the stock price must breach or hold above, providing traders with critical decision points.
Chart Patterns: He discusses chart patterns like head and shoulders, cup and handle, or flags, and their relevance in predicting future price movements. These patterns can offer valuable insights into potential bullish or bearish trends.
Volume Analysis: He emphasizes the importance of volume analysis in confirming price trends. An increase in trading volume during a breakout or breakdown can validate the significance of a price move.
Dave Bartosiak's technical analysis approach adds depth to our understanding Tempus AI stock chart. By paying attention to moving averages, support and resistance levels, chart patterns, technical indicators, and volume, he equips investors with a comprehensive toolkit for making well-informed decisions in the stock market. Remember, while technical analysis is a valuable tool, it's important to consider other factors like fundamental analysis and market sentiment before making investment choices.